Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Protective cell-mediated immunity against Cryptococcus neoformans.

× No keyword cloud information.

16 in total

1. In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis.

Authors: Karen L Wozniak; Jatin M Vyas; Stuart M Levitz
Journal: Infect Immun Date: 2006-07 Impact factor: 3.441

Review 2. Innate host defenses against Cryptococcus neoformans.

Authors: Camaron Hole; Floyd L Wormley
Journal: J Microbiol Date: 2016-02-27 Impact factor: 3.422

3. Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation.

Authors: Donatella Pietrella; Cristina Corbucci; Stefano Perito; Giovanni Bistoni; Anna Vecchiarelli
Journal: Infect Immun Date: 2005-02 Impact factor: 3.441

4. Differences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformans.

Authors: Kasie L Nichols; Sean K Bauman; Fredda B Schafer; Juneann W Murphy
Journal: Infect Immun Date: 2002-02 Impact factor: 3.441

5. Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo.

Authors: Lauren E Yauch; Michael K Mansour; Shmuel Shoham; James B Rottman; Stuart M Levitz
Journal: Infect Immun Date: 2004-09 Impact factor: 3.441

6. Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans.

Authors: Thomas H Rude; Dena L Toffaletti; Gary M Cox; John R Perfect
Journal: Infect Immun Date: 2002-10 Impact factor: 3.441

7. Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection.

Authors: Loïc Guillot; Scott F Carroll; Robert Homer; Salman T Qureshi
Journal: Infect Immun Date: 2008-08-04 Impact factor: 3.441

Protective cell-mediated immunity against Cryptococcus neoformans.